Lululemon (LULU) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Needham cut Apellis Pharmaceuticals, Inc. APLS price target from $85 to $60. Needham analyst Joseph Stringer maintained a Buy ...